Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Zymergen Inc.
  6. Company
    ZY   US98985X1000

ZYMERGEN INC.

(ZY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Zymergen Inc.
Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack that integrates techniques in molecular biology, chemistry, materials science, lab automation systems, software applications, databases and machine learning algorithms. Its biofacturing platform is designed to identify and create biomolecules and insert genes into a host microbe that produces the desired biomolecules. The Company serves to chemicals and materials, agriculture, and pharmaceuticals industries. The Company's product pipeline includes Electronics, Consumer Care, and Agriculture.

Number of employees : 762 people.
Sales per Business
2020
Research and Development Service Agreements9.7973.7%
Collaboration3.4926.3%
Biofacture Products0.000%
USD in Million
Sales per region
20192020Delta
United States11.3973.8%6.1045.9% -46.4%
Asia3.6123.4%4.7435.7% +31.36%
Europe0.432.8%2.4418.4% +473.47%
USD in Million
Managers
Name Title Age Since
Jay Flatley Chairman & Chief Executive Officer 67 2021
Enakshi Singh Chief Financial Officer - 2021
Zachariah Serber, Dr. Director & Chief Science Officer - 2014
Jed Dean, Dr. Vice President-Operations & Engineering - 2014
Aaron Kimball Chief Technology Officer - 2014
Rohit Sharma, Dr. Independent Director - 2015
Matthew Ocko Independent Director 51 2015
Steven J. Chu, Dr. Independent Director 72 2016
Sandra E. Peterson Lead Independent Director 61 2021
Christine Marie Gorjanc Independent Director 63 2021
Members of the board
Name Title Age Since
Jay Flatley Chairman & Chief Executive Officer 67 2021
Zachariah Serber, Dr. Director & Chief Science Officer - 2014
Rohit Sharma, Dr. Independent Director - 2015
Matthew Ocko Independent Director 51 2015
Steven J. Chu, Dr. Independent Director 72 2016
Sandra E. Peterson Lead Independent Director 61 2021
Christine Marie Gorjanc Independent Director 63 2021
Travis Murdoch, Dr. Independent Director - 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 102,389,838 93,260,647 91.1% 0 0.0% 91.1%
Shareholders
NameEquities%
SB Investment Advisers (UK) Ltd. 26,614,219 26.0%
True Ventures LLC 6,955,626 6.79%
GIC Pte Ltd. (Investment Management) 5,078,902 4.96%
Baillie Gifford & Co. 2,821,956 2.76%
Jed Dean 2,800,000 2.73%
Joshua J. Hoffman 2,800,000 2.73%
BAMCO, Inc. 2,666,218 2.60%
Capital Research & Management Co. (World Investors) 2,599,700 2.54%
Capital Research & Management Co. (International Investors) 2,599,700 2.54%
Zachariah Serber 2,560,000 2.50%
Company contact information
Zymergen, Inc.
5980 Horton Street
Suite 105
Emeryville, CA 94608

Phone : +1.415.801.8073
Web : http://www.zymergen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Zymergen Inc.